FDA accepts Teva's drug application for Tourette syndrome therapy in children
Go back to FDA accepts Teva's drug application for Tourette syndrome therapy in children| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 36.19 +0.14 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.05 | 52 Week High | $66.55 | |||
| Open | $36.52 | 52 Week Low | $37.82 | |||
| Day High | $36.55 | P/E | N/A | |||
| Day Low | $35.85 | EPS | $0.00 | |||
| Volume | 3,515,657 | |||||
